- Home
- SABS vs AUST Comparison
SABS vs AUST Comparison
Compare SABS & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- AUST
- Stock Information
- Founded
- SABS 2014
- AUST 2020
- Country
- SABS United States
- AUST Canada
- Employees
- SABS N/A
- AUST N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- AUST
- Sector
- SABS Health Care
- AUST
- Exchange
- SABS Nasdaq
- AUST Nasdaq
- Market Cap
- SABS 19.0M
- AUST 21.5M
- IPO Year
- SABS N/A
- AUST 2022
- Fundamental
- Price
- SABS $1.82
- AUST $1.42
- Analyst Decision
- SABS Strong Buy
- AUST
- Analyst Count
- SABS 5
- AUST 0
- Target Price
- SABS $12.40
- AUST N/A
- AVG Volume (30 Days)
- SABS 246.2K
- AUST 156.5K
- Earning Date
- SABS 03-28-2025
- AUST 03-03-2025
- Dividend Yield
- SABS N/A
- AUST N/A
- EPS Growth
- SABS N/A
- AUST N/A
- EPS
- SABS N/A
- AUST N/A
- Revenue
- SABS $1,512,723.00
- AUST N/A
- Revenue This Year
- SABS N/A
- AUST N/A
- Revenue Next Year
- SABS N/A
- AUST N/A
- P/E Ratio
- SABS N/A
- AUST N/A
- Revenue Growth
- SABS N/A
- AUST N/A
- 52 Week Low
- SABS $1.60
- AUST $0.79
- 52 Week High
- SABS $6.30
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- SABS 36.28
- AUST 49.76
- Support Level
- SABS $2.00
- AUST $1.45
- Resistance Level
- SABS $2.15
- AUST $1.80
- Average True Range (ATR)
- SABS 0.20
- AUST 0.15
- MACD
- SABS 0.03
- AUST -0.00
- Stochastic Oscillator
- SABS 30.99
- AUST 25.49
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About AUST Austin Gold Corp.
Austin Gold Corp is a gold exploration and development company focused on gold targets and making district-scale gold discoveries in Nevada. Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Fourmile Basin in Nye County.